Successful medical treatment of fetal supraventricular tachycardia that cause hydrops fetalis | Zendy

Cihan Çetin | Zendy; Çiğdem Akçabay | Zendy; Selim Büyükkurt | Zendy; Nazan Özbarlas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Successful medical treatment of fetal supraventricular tachycardia that cause hydrops fetalis

Author(s) -

Cihan Çetin,

Çiğdem Akçabay,

Selim Büyükkurt,

Nazan Özbarlas

Publication year - 2014

Publication title -

journal of turkish society of obstetric and gynecology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.41

H-Index - 9

eISSN - 1307-7007

pISSN - 1307-699X

DOI - 10.4274/tjod.56578

Subject(s) - hydrops fetalis , supraventricular tachycardia , medicine , sotalol , digoxin , fetus , cardiology , tachycardia , heart failure , pregnancy , atrial fibrillation , genetics , biology

Supraventricular tachycardia (SVT) is the most frequent fetal tachyarrhythmia. Diagnosis is established with M-mode ultrasound and/or Doppler investigation. Untreated cases may develop fetal heart failure and hydrops. Even these cases should not be left untreated - maternal administration of anti-arrhythmic drugs should be undertaken. In this manuscript, we describe a successful treatment with maternal administration of sotalol and digoxin in a fetus that developed hydrops because of SVT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research